EMD SERONO SPECIALTY DIGEST PDF

The digest compiles survey results from 59 commercial health plan providers. The providers were questioned during the survey period of October to November about key challenges, management strategies, and top initiatives in the future regarding specialty drugs. Discussing key challenges, survey respondents echoed the findings from previous years, but in the survey, determining the value of specialty drugs took the No. Host attributed this, in part, to the continued entrance of new technologies, which challenge health care managers in determining the value of these services. Managing oncology, which survey participants noted as a top challenge, remained in a similar spot as last year, and ensuring clinically appropriate use continued to be listed among top challenges. Lonergan noted that the gap between most cancer management goals and the achievement of those goals had been reduced since the sur- vey, with the No.

Author:Tygorg Kazrami
Country:Burundi
Language:English (Spanish)
Genre:Software
Published (Last):3 August 2017
Pages:331
PDF File Size:11.23 Mb
ePub File Size:18.68 Mb
ISBN:890-5-54967-837-1
Downloads:63910
Price:Free* [*Free Regsitration Required]
Uploader:Fenrill



The digest compiles survey results from 59 commercial health plan providers. The providers were questioned during the survey period of October to November about key challenges, management strategies, and top initiatives in the future regarding specialty drugs. Discussing key challenges, survey respondents echoed the findings from previous years, but in the survey, determining the value of specialty drugs took the No.

Host attributed this, in part, to the continued entrance of new technologies, which challenge health care managers in determining the value of these services.

Managing oncology, which survey participants noted as a top challenge, remained in a similar spot as last year, and ensuring clinically appropriate use continued to be listed among top challenges. Lonergan noted that the gap between most cancer management goals and the achievement of those goals had been reduced since the sur- vey, with the No.

Lonergan attributed this difference in large part to recommendations from the American Society of Clinical Oncology, which recently advocated for more collaboration in the development of clinical pathways. Discussing overall specialty drug management, Host said there is slightly more utilization in the home infusion space compared with the survey findings.

He said outpatient infusion clinic use remained fairly consistent in the and surveys. A key takeaway was that medical benefit cost- sharing strategies seemed to be very common across all sites of care. He added that there remains a great opportunity for specialty pharmacies to distinguish themselves by improving in this area. Similar to the digest survey on oncology, the survey participants included a gap analysis in managing MS, and Lonergan noted that the overall consensus from the survey seemed to indicate that from a health plan perspective, the gaps in managing MS are much smaller than the gaps in the oncology space.

He noted the No. Fewer than one-third of respondents currently use or plan to use clinical pathways for MS, he said. Discussing key initiatives for the future, the panel stressed coordination among benefits, which they concluded is important for patients and providers so that the care will be seamless. The panel also noted the importance of coordinating across departments within health plans, enhancing reporting requirements, and continuing to enhance prior authorizations to ensure clinical effectiveness.

EL OSCURO PASAJERO DE JEFF LINDSAY PDF

Responding to COVID-19

Kagarisar Rebates Reduced Price Growth. Venture Capital Fueling Innovation. Better Use of Medicines. Patient Cost Sharing Rising. Most Common Prescribing Problem. The survey, which was fielded from November 15, to December 28,measured the use of common drug benefit management tools, emerging challenges and opportunities, and assessments of the success of various initiatives. New Generics Are Adopted Regularly.

GEORGE RUSSELL THE LYDIAN CHROMATIC CONCEPT OF TONAL ORGANIZATION PDF

Specialty Pharmaceuticals Update

.

AR 690-400 PDF

.

Related Articles